Sunday, December 15, 2024

Tag: DOH-CHDNM

Focal prophylaxis for schistosomiasis administered in Barangay St. Peter

Posted on by Melchor Madera

MALAYBALAY CITY (May 22, 2024) – The City Health Office (CHO) conducted focal prophylaxis for schistosomiasis in Barangay St. Peter, a non-schisto-endemic area

This demonstrates a commitment to preventive healthcare and addressing potential health risks before they become significant problems.

By conducting such interventions, they’re not only protecting the health of individuals in Barangay St. Peter but also working towards preventing the spread of schistosomiasis to other areas.

Individuals aged 5 to 65 years old were administered a single dose of Praziquantel (40mg/kg) on a full stomach.

This intervention followed Malacological and Parasitological surveys by the City Health Office, which identified the presence of schistosomiasis in Barangay St. Peter.

During the malacological survey, the snail Oncomelania quadrasi, the intermediate host of Schistosoma japonicum, was found.

In a subsequent parasitological survey, 100 stool samples were examined using the Katokatz method, revealing that less than 1 percent were positive for schistosomiasis and soil- transmitted helminthiasis in the place.

In response, the Department of Health Center for Health and Development Northern Mindanao (DOH-CHDNM) provided Praziquantel, the preferred drug for treating schistosomiasis.

Following health advisories, a mass treatment approach was adopted, providing prophylactic treatment to the entire eligible population, regardless of infection status.

By treating everyone within the eligible age range, the intervention aims to prevent new infections and reduce the overall burden of the disease in the community. (CHO-NADA/melbmadera)

DOH-10 urges public to buy generic medicines, same quality but cheaper

Posted on by cmn

CAGAYAN DE ORO CITY (PIA)–The generic drugs have the same quality and effectiveness as the branded versions because they go through similar regulatory processes at the Food and Drug Administration (FDA), but they are cheaper, said an official from the Department of Health-Center for Health Development Northern Mindanao (DOH-CHDNM)

In Talakayan sa PIA: Konsultayo Series at SM CDO City Uptown, Dr. Steffi Grace Enon, medical officer of DOH-CHDNM, said generic medicine has the same active ingredient as the branded version, so it has the same effect.

Why is there generic medicine?

The Generics Act of 1988 ensures that all Filipinos have access to affordable and effective medicines.

Enon shared that there are two main types of medicines. The first is innovator medicine, which is made by pharmaceutical companies that are the ones to create the medicine first for a specific disease. They also apply for patents for the drug, which means they have the sole right to make and sell the drug. But after a few years, with the patent expired, other manufacturers can then create the same drug.

According to Enon, all generic medications on the market underwent and passed the FDA process, while our generic medications met the same standards of quality as branded medications.

DOH-CHDNM is requiring pharmaceutical companies to do mandatory generic labeling. “Tanan tambal dapat nakasulat didto ang generic nga ngalan [All medicine should have a generic name],” said Enon.

They are also reminding physicians and doctors to include in their prescriptions the generic name of the drug.

Lastly, DOH-CHDNM also reminds pharmacies to do generic dispensing or substitution. This means that when a patient goes to the pharmacy and asks for a generic prescription, he or she should be given the generic version of the drug.

There is also the Cheaper Medicines Act, which was issued in 2008 and is an amendment to the Generics Medicine Act.

The goal is to ensure there are generic versions available on the market. The Cheaper Medicines Act intends to lower the prices of medicine even more.

There are various ways to implement the law, Enon said. There is a maximum retail price, and there is a price cap for medicines that belong to the top-burden diseases in the Philippines, like high blood pressure, diabetes, and cancer, among others.

Second, there is a suggested retail price (SRP) for essential and emergency medicine.

“Mandated tanan nato drugstores and pharmacies, mag-submit sa Department of Health sa ilang presyo sa mga tambal [We have mandated drugstores and pharmacies to submit to the Department of Health the prices of their medicines],” said Enon.

Third is the drug price reference index. Basically, this is a list of the prices of medicines for bidding from the government.

“Kung mupalit ang isa ka government facility or agency, mu-abide gyud sila ani nga presyo [If a government facility or agency will buy, they need to abide by the set price],” added Enon. (JMOR/PIA-10)

BFAR debunks rumors of HIV-infected fish, seafood being sold in Normin

Posted on by cmn

CAGAYAN DE ORO CITY (PIA)–The Bureau of Fisheries and Aquatic Resources (BFAR)-10 on Wednesday said there is no truth to rumors being spread online that HIV-infected medical waste that was found dumped in waters in this region has contaminated fish and seafood being sold in markets

“We want to emphasize that consuming fishery products is safe and poses no risk of contracting HIV. HIV is a virus that primarily spreads through specific human bodily fluids, such as blood, sexual fluids, and breast milk, and is not transmitted through the consumption of food, including fish and seafood,” BFAR-10 Regional Director Edward Yasay said.

Recent misleading social media posts have been circulating online, suggesting that HIV-infected medical tools found in the waters of the region (with no particular location specified) are causing seafood to carry the virus. BFAR-10 clarified that these claims are false and unsubstantiated. The Department of Health Center for Health Development Northern Mindanao (DOH-CHDNM) has verified that there is no basis for such allegations.

In addressing public health concerns, Yasay emphasized that it is vital to rely on credible sources and accurate information.

“We encourage all consumers to be vigilant about the information they encounter online and to consult reputable health organizations and authorities for accurate and trustworthy information regarding public health and food safety,” he added.

BFAR-10, through its Fisheries Integrated Laboratory Section (FILS) and Fisheries Inspection and Quarantine Unit (FIQU), is fully committed to ensuring the safety and quality of fishery products available in the market. Fisheries inspectors and stringent regulatory measures are in place to monitor and regulate seafood, ensuring it meets the highest safety and hygiene standards.

Yasay urged the public to continue trusting fishery products as a safe and nutritious source of food. He assured that BFAR-10 remains dedicated to safeguarding the well-being of consumers and ensuring that the region’s fishery products meet the highest standards of safety and quality. (RTP/PIA-10)

DOH-10 urges public to buy generic medicines same quality but cheaper

Posted on by cmn

CAGAYAN DE ORO CITY (PIA)–The generic drugs have the same quality and effectiveness as the branded versions because they go through similar regulatory processes at the Food and Drug Administration (FDA), but they are cheaper, said an official from the Department of Health-Center for Health Development Northern Mindanao (DOH-CHDNM)

In Talakayan sa PIA: Konsultayo Series at SM CDO City Uptown, Dr. Steffi Grace Enon, medical officer of DOH-CHDNM, said generic medicine has the same active ingredient as the branded version, so it has the same effect.

Why is there generic medicine?

The Generics Act of 1988 ensures that Filipinos can access affordable and effective medicines.

Enon shared that there are two main types of medicines. The first is innovator medicine, which is made by pharmaceutical companies that are the ones to create the medicine first for a specific disease. They also apply for drug patents, meaning they have the sole right to make and sell the drug. But after a few years, with the patent expired, other manufacturers can then create the same drug.

According to Enon, all generic medications on the market underwent and passed the FDA process, while our generic medications met the same quality standards as branded medications.

DOH-CHDNM is requiring pharmaceutical companies to do mandatory generic labeling. “Tanan tambal dapat nakasulat didto ang generic nga ngalan [All medicine should have a generic name],” said Enon.

They also remind physicians and doctors to include the generic name of the drug in their prescriptions.

Lastly, DOH-CHDNM also reminds pharmacies to do generic dispensing or substitution. This means that when a patient goes to the pharmacy and asks for a generic prescription, he or she should be given the generic version of the drug.

There is also the Cheaper Medicines Act, which was issued in 2008 and is an amendment to the Generics Medicine Act.

The goal is to ensure there are generic versions available on the market. The Cheaper Medicines Act intends to lower the prices of medicine even more.

There are various ways to implement the law, Enon said. There is a maximum retail price and a price cap for medicines that belong to the top-burden diseases in the Philippines, like high blood pressure, diabetes, and cancer, among others.

Second, there is a suggested retail price (SRP) for essential and emergency medicine.

“Mandated tanan nato drugstores and pharmacies, mag-submit sa Department of Health sa ilang presyo sa mga tambal [We have mandated drugstores and pharmacies to submit to the Department of Health the prices of their medicines],” said Enon.

Third is the drug price reference index. Basically, this is a list of the prices of medicines for bidding from the government.

“Kung mupalit ang isa ka government facility or agency, mu-abide gyud sila ani nga presyo [If a government facility or agency will buy, they need to abide by the set price],” added Enon. (JMOR/PIA-10)

PSPME holds consultations for children with endocrine disorders

Posted on by cmn

The Philippine Society of Pediatric Metabolism & Endocrinology (PSPME), in collaboration with the Malaybalay City Health Office (CHO) and the Department of Health – Northern Mindanao (DOH-CHDNM), hosted a consultation event on September 28, 2023, at Loiza’s Pavilion, Malaybalay City

The event aimed to provide essential follow-up care for children diagnosed with congenital hypothyroidism and congenital adrenal hyperplasia.

Distinguished members of the Philippine Society of Pediatric Metabolism & Endocrinology (PSPME) leading the event included Dr. Jedeabe Aragon and Dr. Maria Luisa Malabuyoc, both renowned experts in pediatric endocrinology. Additionally, healthcare professionals from Newborn Screening Continuity Clinics (NMMC and BPMC), including Dr. Rhona Ortencio-Ocho and Udall Armand Cabading from NMMC, and Dr. Aileen Dubrigue and Ian Roy Lapinid from BPMC, contributed their expertise. Dr. Miguel Antonio Prantilla, Chief of the Hospital at BPMC, and Dr. Melodee Aguirre, Pediatric Department Head at BPMC, were also in attendance.

Dr. Melirose Deticio, CHO-I and Medical Coordinator for Newborn Screening, along with dedicated CHO midwives and representatives from Human Resources for Health (HRH), played a crucial role in organizing the event. Kharl Karen Libot, the Nurse Coordinator for Newborn Screening, also ensured the smooth execution of the consultation.

Upon arrival, the children and their parents underwent registration and had their anthropometric measurements taken to monitor their growth and development.

Dr. Maria Luisa Malabuyoc delivered a lecture on endocrine disorders, providing valuable insights and guidance to the attendees.

The heart of the event revolved around consultations with 18 children diagnosed with congenital hypothyroidism and congenital adrenal hyperplasia. Of these, 16 hailed from Malaybalay City, while 2 were from Valencia City. These one-on-one consultations allowed for personalized care plans and addressing the specific needs of each child.

As part of the commitment to the well-being of these children, free levothyroxine medications were distributed, ensuring that they receive the necessary treatment to manage their conditions effectively.

The event represents a significant step in providing continued care and support to these young patients, ultimately contributing to their better quality of life. (LGU Malaybalay)

DOH-10 inaugurates Normin regional blood center

Posted on by cmn

CAGAYAN DE ORO CITY (PIA)–The Department of Health Center for Health Development Northern Mindanao (DOH-CHDNM) inaugurates its Northern Mindanao Regional Blood Center (NMRBC) on June 30

The NMRBC is a project under the Health Facility Enhancement Program (HFEP) of the Department of Health that

aims to improve access to quality healthcare facilities and services in the region. The construction of the building started in 2018 under the leadership of then-DOH-10 Regional Director Dr. Nimfa Torrizo, which Regional Director Dr. Jose Llacuna, Jr later carried over.

The blood center is designed to be the central storage facility for donated blood in the region. Since the center is still in its infancy, the DOH-CHDNM will work alongside the Philippine Red Cross until the facilities are fully operational.

Meanwhile, the health department hopes the public will understand and realize the importance of voluntary blood donation to save lives.

“Ang pag-construct ng mga ganitong gusali or facilities, hindi ito guarantee na consistent ang availability ng blood. Kahit meron tayong ganito kung di natin bibigyan ng tamang paraan upang magkaroon ng voluntary blood donors at magkaroon nang-stock dito wala tong kwenta ang building na ito. We need to give extra effort to make the program responsive to the needs of the people,” DOH Undersecretary for Field Implementation and Coordination Team-Mindanao, Abdullah Dumama, Jr., said. (The construction of such buildings or facilities does not guarantee the consistent availability of blood. Even if we have something like this, if we provide the right way to have voluntary blood donors and have stock here, this building will be valuable. We need to give extra effort to make the program responsive to the needs of the people)

Admittedly, the health department acknowledges the need to improve the safe blood collection and distribution system; hence, they are working with partners and stakeholders to establish a more responsive blood donation program.

“All of these accomplishments have been able to be achieved because of the cooperation of all stakeholders, and we hope that in the coming years, with the blessing from God above, we will be able to serve our Filipino people, especially those who have less in life, for they deserve more from us,” DOH-10 Regional Director Jose Llacuna said. (JAKA/PIA-10)

Bivalent vaccines launched in Normin

Posted on by cmn

CAGAYAN DE ORO CITY (PIA)–To further boost the protection of healthcare workers and senior citizens in Northern Mindanao, the Department of Health Center for Health Development Northern Mindanao (DOH-CHDNM) officially launched the COVID-19 Bivalent Vaccination drive for Northern Mindanao, June 29

The bivalent vaccine, produced by Pfizer Pharmaceutical, contains the original strain of COVID-19 with an added strain of the omicron component BA.4-5 for better prevention of COVID-19 caused by the omicron variant of SARS-COV-2.

“As a matter of principle, since there is a limitation on supply, we prioritize the health workers (A1) and senior citizens (A2). We have an initial allocation of about 16,440 doses for Northern Mindanao for its initial

implementation,” DOH-10 Regional Director Jose R. Llacuna, Jr. said.

With the arrival of the vaccines, two launch sites were established by the health department to officially kick off the bivalent vaccination implementation, namely, the Northern Mindanao Medical Center (NMMC) and Sitio Macanhan, Carmen, Cagayan de Oro City.

Despite the limited number of vaccines, Llacuna has assured the healthcare workers in NMMC that additional supplies are expected to arrive in the coming weeks and that bivalent immunization will commence in the different areas of the region.

“We will wait for about four to six months after the second [booster] dose before those will qualify for the bivalent dose,” Llacuna added.

Meanwhile, with the launch of bivalent vaccination in Cagayan de Oro City, the city government has fully supported the program. Hundreds of senior citizens have lined up for the third booster dose at the vaccination site.

As the campaign for the third booster dose commences, both DOH-10 and the City Government of Cagayan de Oro City urge all senior citizens to avail themselves of the program to protect them against COVID-19 further. (JAKA/PIA-10)